Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development COVID-19, Contract Development Services, Contract Manufacturing Services

Post-Pandemic Planning: What Will Change in Early-Phase Drug Development?

sponsored by Thermo Fisher Scientific

Available On-Demand

June 30th, 2020, 11am EDT

Even as governments around the world begin to re-open, COVID-19 will have a lasting impact on how the pharmaceutical industry functions both in the immediate future and long-term. The development, trial and manufacture of medications will drastically change as sponsors find new ways to interact with both contract manufacturing organizations and patients. How can you navigate this unprecedented environment while still meeting milestones? Join Thermo Fisher Scientific’s drug development and manufacturing experts for a unique, extended Q&A session and learn how to start navigating the new normal.

Key Learning Objectives:

  • The impact of COVID-19 on sponsor/CDMO relationships moving forward 
  • How Thermo Fisher Scientific has maintained normal CDMO operations and plans to shift to meet new needs 
  • Answers to your questions surrounding the new post-pandemic landscape

Available On-Demand

Subscribe to The Medicine Maker Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine